3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole and beta-funaltrexamine

3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole has been researched along with beta-funaltrexamine in 1 studies

Compound Research Comparison

Studies (3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole)	Trials (3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole)	Recent Studies (post-2010) (3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole)	Studies (beta-funaltrexamine)	Trials (beta-funaltrexamine)	Recent Studies (post-2010) (beta-funaltrexamine)
11	0	0	542	1	54

Protein Interaction Comparison

Protein	Taxonomy	beta-funaltrexamine (IC50)
Muscarinic acetylcholine receptor M2	Rattus norvegicus (Norway rat)	0.082
Prostaglandin G/H synthase 1	Homo sapiens (human)	0.082
Delta-type opioid receptor	Mus musculus (house mouse)	0.082
Kappa-type opioid receptor	Mus musculus (house mouse)	0.082
Mu-type opioid receptor	Mus musculus (house mouse)	0.082

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, T; Goto, T; Motoyama, Y; Ochi, T	1

Other Studies

1 other study(ies) available for 3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole and beta-funaltrexamine

Article	Year
Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors. European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3 Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Binding, Competitive; Diarrhea; Injections, Intraventricular; Injections, Spinal; Male; Membranes; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pyrazoles; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord; Sulfoxides	1999

Article

Year

Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.

European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3

Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Binding, Competitive; Diarrhea; Injections, Intraventricular; Injections, Spinal; Male; Membranes; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pyrazoles; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord; Sulfoxides

1999